Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T12:01:41.035Z.
Calculation as of: 2026-10-06T12:01:41.035Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea268c636d02c1563f9a0cc17fa45ef3048b6802d4031696aa30e1bc9d7aaf2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Connect Biopharma Holdings Limited
Market Cap
$56.54M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $56.54M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $55.72M | N/A | 4.74 | 4.40 | 4.40 |
| Boundless Bio, Inc. (BOLD)vs › | $58.43M | N/A | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.48M | N/A | 16.03 | 122.62 | 125.37 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | 242.77 | 158.30 | 158.03 | 959.94 |
| Clene Inc. (CLNN)vs › | $49.96M | 253.62 | 342.08 | 169.55 | 218.69 |
Half-year reporter: no trailing two-half-year basis, because the half-year figures do not reconcile with the annual report: the newest completed fiscal year's two halves differ from its annual revenue or net income by more than 5%.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
